GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: CORPORATE NEWS

TOP CORPORATE NEWS- 14 DEC 2018

ONGC gains 3% on share buyback proposal Shares of Oil & Natural Gas Corpn (ONGC) gained 3% on Friday after the company in its filing to the exchanges informed that its board of directors would consider a buyback proposal in a meeting on December 20. Further, for the prohibition of insider trading in dealing with

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 14 DEC 2018

The NSE benchmark Nifty extended its northward movement for a third consecutive day. However, in the last hour of trading, a bout of volatility was seen and, as a result, Nifty closed off the day’s high. The price action formed a high wave candle with small real body and shadows on either side, indicating hesitation

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 12 DEC 2018

The NSE benchmark Nifty witnessed a gap-down opening; however, the end was not less than a fairy tale as Nifty not only erased its losses but ended the session above the 10,500 mark with a gain of 0.58 per cent. The price action formed a significant bull candle. Nifty took support near the key Fibonacci

TOP CORPORATE NEWS- 03 Dec 2018

HUL’s food & refreshment biz to get a ‘boost’ as board approves GSK Consumer merger deal The board of Hindustan Unilever (HUL) has approved the scheme of amalgamating the company and GlaxoSmithKline (GSK) Consumer Healthcare Ltd (GSKCH), subject to further approvals. The transaction is an all-equity merger with 4.39 shares of HUL being allotted for

TOP CORPORATE NEWS- 29 NOV 2018

Yes Bank bounces back after hitting 52-week-low Shares of Yes Bank rebounded after falling 9% in Thursday’s trade to touch a fresh 52-week low as well as a 33-month low. The private sector lender’s stock has tanked 19% in the past three days after Moody’s downgraded the bank’s instruments and changed its outlook from stable

TOP CORPORATE NEWS- 27 NOV 2018

Cadila gets final USFDA approval for Baclofen Tablets Cadila Healthcare has received a final approval from the US Food & Drug Administration (USFDA) to market Baclofen Tablets (US RLD- Lioresal®), 10 mg and 20 mg. Despite the news, shares of the company dropped 2% on Tuesday. The company will produce Baclofen Tablets from its formulations

CapitalStars FORUM